CannaCure Florida to Host November Medical Cannabis Education Conference in Tampa
CannaCure Florida, a patient-focused producer of medical cannabis and related products, will host physicians and medical professionals for a peer-to-peer…
Articles by Patricia Silva, PhD
‘Rare’ Molecule in Immune System Turns Out to Be Common, and May Be Part of What Goes Wrong in MS
Researchers have discovered that a type of immune molecule — called “spliced epitopes,” once believed to be very rare  —…
Genome-wide Analysis Pinpoints 200 Gene Variants Common to MS
A genome-wide analysis of over 110,000 people allowed researchers with the International Multiple Sclerosis Genetics Consortium (IMSGC) to discover 200 genetic loci (the position of genes…
RedHill Awaits Patent for RHB-104, Potential MS Treatment, from Japan
RedHill Biopharma recently announced that it has received a Notice of Allowance from the Japan Patent Office for a new patent covering RHB-104…
Apitope Regains Full Rights to Potential MS Therapy, ATX-MS-1467
Apitope and Merck KGaA announced that they have entered into an exclusive agreement regarding ATX-MS-1467, a potential disease-modifying therapy for  multiple sclerosis…
Smyle Mouse Relies on Facial Gestures to Let Users Control Their Computer
Using a computer mouse can be difficult for people with the many diseases or injuries that affect muscular control, including…
MS Society Awards Almost $220K to Research into Myelin Repair and Renewal
The MS Society in the United Kingdom awarded £177,930 (about $217,800) to Dr. Sassan Hafizi, a researcher at University of…
Lemtrada Seen to Help Reverse MS Disability in People in Earlier Stages of Disease
Lemtrada (alemtuzumab) was seen to help reverse disability among patients with relapsing forms of multiple sclerosis (MS) in relatively early…
National Multiple Sclerosis Society Commits $10.5M to Fund 42 Research Efforts
The National Multiple Sclerosis Society announced that is investing more than $10.5 million to support an anticipated 42 new research projects into multiple…
Selective Manipulation of Specific Receptors May Pave Way for New MS Therapies
Mouse experiments with compounds having opposite actions on two receptors for TNF (tumor necrosis factor) — a key factor in…
Regular Exercise Found to Repair Damage to Neurons in Brains of Mice
Voluntary running triggers a molecule called VGF, a nerve growth factor, that was seen to induce a brain repair mechanism in…
Heparin for MD Myelin Repair to Be Studied in United Kingdom
The MS Society in the United Kingdom is funding a new project at the University of Glasgow, in Scotland, to…
Neurologists Anticipate FDA Approval of Ocrevus as 1st Progressive MS Treatment, Survey Finds
Neurologists in the U.S. expect — or, at least, highly anticipate — that Ocrevus (ocrelizumab), being developed by Roche…
The ABLE Act: A Tax-free Benefit for People with MS That Could Be Better
Disability from multiple sclerosis develops, on average, within 10Â years of diagnosis. Financial catastrophe was often the consequence,…
Vocalist Lori Jenaire Supports #25for25 Campaign for Autoimmune Diseases with ‘As You Are’ Classic Cover
Singer-songwriter Lori Jenaire is supporting the American Autoimmune Related Diseases Association (AARDA) #25for25 fundraising campaign with the release of her…
New Urinary Catheter, Designed by Quadriplegic, Approved by FDA
The U.S. Food and Drug Administration (FDA) approved for marketing Adapta Medical’s PerfIC Cath, an intermittent and easy-to-use urinary catheter that…
GeneFo Webinar Explores Potential of Mushrooms to Help Manage MS
GeneFo, an MS patient community that provides support, advice, and clinical trial matching, recently co-hosted an online conference with Trent…
Celgene Partners with Abide to Bring Cannabis-like Treatment for MS into Further Clinical Tests
Abide Therapeutics announced that Celgene has opted to obtain the rights, outside of the United States, to ABX-1431, Abide’s…
PathMaker Wins Innovation Prize for Neurotherapies to Treat Spasticity, Muscle Weakness
PathMaker Neurosystems is the winner of the Universal Biotech Innovation Prize 2016 for its innovative, non-invasive neurotherapy technologies to treat conditions linked to neural pathway…
MS Trust to Oppose NICE Plan to Reject Zinbryta as MS Therapy in Health System for England, Wales
The Multiple Sclerosis (MS) Trust is expressing its disappointment at the recent committee decision of the National Institute for Health and Care Excellence (…
Mindfulness Training Seen to Help People Adjust to Chronic Ills Like MS
A researcher at De Montfort University Leicester (DMU)’s School of Nursing and Midwifery found that the practice of mindfulness helps…
NICE Planning to Reject MS Treatment, Zinbryta, in England and Wales
The National Institute for Health and Care Excellence (NICE), the health authority for England and Wales, has decided not to recommend…
Lifelong Exercise Doesn’t Lower the Risk of Multiple Sclerosis, Large Study in Women Reports
In a large prospective study with validated measures of physical activity, researchers found no evidence that exercise reduced a woman’s risk…
Phase 3 Study to Test Oral Combination, Tecfidera and Ponesimod, to Treat Relapsing MS
Actelion announced that it will investigate the therapeutic potential of a new, oral combination therapy with ponesimod and Tecfidera (dimethyl fumarate)…
Instability of Myelin Membranes May Be True Trigger of MS, Study Reports
In multiple sclerosis (MS), scientists have long believed that the body’s own immune system attacked myelin sheaths, the “insulating tape” that surrounds…
National MS Society Calls on Leaders to Lower Prices and Improve Access to MS Medications
The National Multiple Sclerosis Society has launched an initiative, called Make MS Medications Accessible, calling for change in the pricing of…
McGill Scientist to Use $6.1M PMSA Award to Search for Markers of Change in Progressive MS
In its effort to end progressive multiple sclerosis (MS), the International Progressive MS Alliance (PMSA) has awarded a $6.1…
Future MS Treatment: Selectively Targeting T-cells May Come As Temporary Tattoo
Antioxidant-filled nanoparticles injected under the skin may become a future multiple sclerosis (MS) treatment that comes with a perk or…
How Tecfidera Works to Reduce MS Relapses Finally Discovered, May Lead to Better Treatments
How the multiple sclerosis (MS) therapy Tecfidera (dimethyl fumarate) works on a molecular level has finally been uncovered, using a new method that can map…
Change in Clinical Test Dose of Potential MS Therapy, Laquinimod, Triggers FDA Response
Active Biotech acknowledged in an update on laquinimod, the oral small molecule being developed by Teva Pharmaceutical Industries to treat …